title: The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia.
authors.forename: Do-Un
authors.initials: DU
authors.lastname: Jung
authors.forename: Young-Soo
authors.initials: YS
authors.lastname: Seo
authors.forename: Jae-Hoon
authors.initials: JH
authors.lastname: Park
authors.forename: Chi-Young
authors.initials: CY
authors.lastname: Jeong
authors.forename: Robert R
authors.initials: RR
authors.lastname: Conley
authors.forename: Deanna L
authors.initials: DL
authors.lastname: Kelly
authors.forename: Joo-Cheol
authors.initials: JC
authors.lastname: Shim
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D002908:Chronic Disease; D004334:Drug Administration Schedule; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage*; D006801:Humans; D006966:Hyperprolactinemia / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011388:Prolactin / Q000097:blood; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D012737:Sex Factors
chemical_list: D014150:Antipsychotic Agents; D011388:Prolactin; D006220:Haloperidol